Načítá se...
Clozapine treatment of refractory schizophrenia during essential chemotherapy: a case study and mini review of a clinical dilemma
BACKGROUND: Clozapine remains the antipsychotic of choice for refractory schizophrenia. Given the particular side effects of clozapine including neutropenia and myelosuppression, safety and efficacy of add-on chemotherapy for patients who are already under clozapine treatment remain unknown. OBJECTI...
Uloženo v:
| Vydáno v: | Ther Adv Psychopharmacol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4257985/ https://ncbi.nlm.nih.gov/pubmed/25489479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125314553610 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|